Atrial Fibrillation Clinical Trials 2024

Atrial Fibrillation Clinical Trials 2024

Atrial Fibrillation research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in atrial fibrillation clinical trials today.

Atrial Fibrillation Clinical Trials

Here are the 6 most popular medical studies for atrial fibrillation

Popular filter options for atrial fibrillation trials

AFib Clinical Trials

View 99 AFib medical studies.

Stroke Clinical Trials

View 14 Stroke medical studies.

Phase 3 Atrial Fibrillation Clinical Trials

View 99 phase 3 atrial fibrillation medical studies.

Atrial Fibrillation Clinical Trials With No Placebo

View 99 atrial fibrillation medical studies that do not have a placebo group.

View More Atrial Fibrillation Trials

See another 77 medical studies focused on atrial fibrillation.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to atrial fibrillation

What are the top hospitals conducting atrial fibrillation research?

When it comes to advancing the treatment options for atrial fibrillation, several hospitals are leading the way. Massachusetts General Hospital in Boston is at the forefront with nine active clinical trials focused on this heart condition. With a remarkable history of 61 completed atrial fibrillation trials dating back to their first recorded trial in 2003, this renowned institution is making significant strides toward improving patients' lives. In Canada's capital city, the University of Ottawa Heart Institute has also emerged as a key player in atrial fibrillation research. They currently have nine ongoing trials and have conducted 29 studies since initiating their first trial in 2000.

Further north, the Montreal Heart Institute has achieved notable progress with six active clinical trials and a total of 26 previous investigations dedicated to understanding and treating atrial fibrillation since recording their inaugural trial twenty years ago. Meanwhile, Grandview Medical Center in Birmingham may be newer to the scene but is already making an impact with six ongoing clinical trials that focus on this irregular heartbeat disorder; they commenced their first study just eight years ago,in2013.

Lastly,Cleveland Clinic located at Cleveland joins these esteemed institutions with five current atrial fibrillation clinical trials under its belt along with twenty-eight prior studies from its outset nineteen years ago,in1999.Their collective efforts showcase dedication and innovation as they strive towards finding better solutions for those affected by this common cardiac condition.

These hospitals serve as beacons of hope for individuals living with or at risk of developing atrial fibrillation. Through cutting-edge research and collaborative efforts among healthcare professionals, breakthroughs are being made every day that bring us closer to improved treatments and management strategies for this complex heart rhythm disorder

Which are the best cities for atrial fibrillation clinical trials?

When it comes to atrial fibrillation clinical trials, several cities lead the way in advancing research and treatment options. New york, with its 28 active trials, focuses on innovative approaches like Pulse Field Ablation and the WATCHMAN FLX Implant. Montreal follows closely behind with 23 ongoing studies exploring Catheter ablation and medications such as Apixaban and Acetylsalicylic acid (ASA). Boston also plays a significant role with 21 active trials investigating therapies like Antiplatelet Therapy and Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder). Toronto and Ottawa are other notable cities contributing to this field of study. These cities offer individuals with atrial fibrillation access to cutting-edge clinical trials that pave the way for improved management of this condition.

Which are the top treatments for atrial fibrillation being explored in clinical trials?

Clinical trials are shedding light on the top treatments being explored for atrial fibrillation. Among these potential options, intervention takes the lead with four active trials and a history of two all-time atrial fibrillation trials since its inception in 2012. Apixaban follows closely behind, participating in two ongoing studies and contributing to a total of 47 clinical trials focused on atrial fibrillation since its introduction in 2007. Catheter ablation also shows promise, joining apixaban with two active trials and an impressive record of 28 all-time atrial fibrillation trials dating back to 2009. Additionally, amiodarone emerges as another contender with two current research endeavors and involvement in 34 all-time clinical trials targeting atrial fibrillation after its debut in 1998. Lastly, a novel approach emerges—12-week supervised exercise-based cardiac rehabilitation program—with one ongoing trial marking the first exploration into this innovative treatment option in early 2022.

What are the most recent clinical trials for atrial fibrillation?

Exciting advancements are taking place in the field of atrial fibrillation as recent clinical trials explore potential breakthrough treatments. One such trial focuses on the use of stellate ganglion block, investigating its effectiveness in managing atrial fibrillation. Another study examines an as-needed rate control approach to treating this condition. Additionally, research is underway to assess the efficacy of Asundexian and colchicine arm for atrial fibrillation patients. Furthermore, a phase 4 trial evaluates the benefits of oral anticoagulants specifically tailored to individuals with atrial fibrillation. These trials offer hope for improved management and treatment options for those living with this cardiovascular disorder.

What atrial fibrillation clinical trials were recently completed?

In the realm of atrial fibrillation, several noteworthy clinical trials have recently concluded, paving the way for advancements in treatment. The St. Vincent Cardiovascular Research Institute wrapped up a trial investigating Colchicine in May 2021, while Wake Forest University Health Sciences completed their Methohexital study in April 2020. Furthermore, Allergan's AGN-151607 trial reached completion milestone back in March 2019. Additionally, the Population Health Research Institute conducted a Colchicine trial which finished in February 2018. These significant research endeavors contribute to our understanding and potential management options for atrial fibrillation patients on their journey towards improved heart health.